PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930040
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930040
Antibiotics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
Growth Factors of antibiotics Market
The global antibiotics market plays a vital role in modern healthcare by treating a wide range of bacterial infections affecting millions of patients worldwide. Antibiotics are commonly used for respiratory infections, urinary tract infections (UTIs), skin infections, gastrointestinal infections, septicemia, and other serious conditions. Despite growing concerns around antimicrobial resistance (AMR), antibiotics remain essential, driving sustained market demand.
Market Size and Forecast
According to Fortune Business Insights, the global antibiotics market size was valued at USD 43.17 billion in 2025. The market is projected to grow to USD 44.84 billion in 2026 and further reach USD 64.38 billion by 2034, expanding at a CAGR of 4.40% during the forecast period (2026-2034).
North America dominated the market in 2025 with a 45.44% market share, supported by advanced healthcare infrastructure, high prescription rates, and strong presence of leading pharmaceutical companies.
Market Drivers
One of the primary drivers of the antibiotics market is the rising prevalence of bacterial infections globally. Conditions such as tuberculosis, pneumonia, UTIs, surgical site infections, and bloodstream infections continue to increase demand for effective antibacterial therapies.
For instance, as per the WHO Global Tuberculosis Report 2024, approximately 10.8 million people worldwide were affected by tuberculosis in 2023. Additionally, healthcare-associated infections (HAIs) remain a major concern, with 1 in 10 patients globally affected, particularly in low- and middle-income countries. These factors significantly propel antibiotic consumption and market growth.
Another major driver is the increase in research and development (R&D) activities, especially focused on addressing drug-resistant infections through novel and combination antibiotic therapies.
Market Restraints
Despite strong demand, the market faces restraints due to stringent regulations aimed at reducing antibiotic misuse and overuse. Governments and healthcare authorities are actively implementing antimicrobial stewardship programs to combat AMR.
Data published in The Lancet highlights that antimicrobial resistance directly caused 1.14 million deaths in 2021, with projections estimating up to 10 million deaths annually by 2050 if current trends continue. Moreover, AMR is expected to add USD 1.0 trillion in healthcare costs by 2050, placing additional strain on healthcare systems and limiting antibiotic adoption.
Market Opportunities
The growing burden of antibiotic-resistant infections presents a significant opportunity for the development of novel and advanced antibiotic therapies. Pharmaceutical companies are increasingly focusing on combination drugs and next-generation antibiotics.
For example, in February 2025, AbbVie Inc. received FDA approval for EMBLAVEO (aztreonam and avibactam) for treating complicated intra-abdominal infections. Such approvals are expected to unlock new revenue streams and strengthen future market growth.
Market Trends
A key trend shaping the antibiotics market is the global adoption of Antimicrobial Stewardship Programs (ASPs). These initiatives aim to promote responsible antibiotic use, reduce resistance, and improve treatment outcomes.
In March 2024, the ASPIRE initiative launched in Africa to enhance antibiotic usage through digital innovation, education, and policy interventions. Such programs are redefining antibiotic prescribing practices worldwide.
Segmentation Insights
- By Drug Class:
Penicillin dominated the market, accounting for 28.59% share in 2026, driven by affordability and increasing generic launches. Cephalosporins are expected to grow at a higher CAGR due to regulatory approvals and broad-spectrum efficacy.
- By Application:
The respiratory infections segment led with a 23.75% share in 2026, supported by the high global burden of pneumonia and other respiratory diseases.
- By Route of Administration:
Parenteral antibiotics held 58.08% market share in 2026, mainly due to their effectiveness in severe and hospital-acquired infections.
- By Distribution Channel:
Hospital pharmacies dominated with 60.71% market share in 2026, while online pharmacies are projected to grow at the fastest rate.
Regional Outlook
- North America: Market valued at USD 19.49 billion in 2025 and USD 20.26 billion in 2026.
- Asia Pacific: Expected to grow at the highest CAGR due to high consumption and availability of low-cost generics.
- Europe: Strong R&D ecosystem and regulatory support for innovative antibiotics.
Competitive Landscape
The market is semi-fragmented, with key players including Pfizer Inc., Sandoz Group AG, Astellas Pharma Inc., Merck & Co., GSK plc, and AbbVie Inc. These companies focus on generic expansion, R&D investment, acquisitions, and collaborations to strengthen global presence.
Conclusion
In conclusion, the global antibiotics market is set for steady growth from USD 43.17 billion in 2025 to USD 64.38 billion by 2034, despite regulatory challenges and antimicrobial resistance concerns. Rising bacterial infections, increased R&D investment, and the development of novel combination therapies continue to support market expansion. While antimicrobial stewardship programs may reduce misuse, they also promote sustainable and effective antibiotic utilization, ensuring long-term market stability and innovation-driven growth.
Segmentation Drug Class, Application, Route of Administration, Distribution Channel, and Region
By Drug Class * Penicillin
- Cephalosporin
- Aminoglycosides
- Tetracycline
- Macrolides
- Fluoroquinolones
- Sulfonamides
- Others
By Application * Skin Infections
- Respiratory Infections
- Urinary Tract Infections
- Septicemia
- Ear Infection
- Gastrointestinal Infections
- Others
By Route of Administration * Oral
- Parenteral
- Others
By Distribution Channel * Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region * North America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country)
- U.S.
- Canada
- Europe (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Drug Class, Application, Route of Administration, Distribution Channel, and Country/Sub-region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Pipeline Analysis, By Key Players
- 4.2. Overview of Antimicrobial Treatment Guidelines
- 4.3. Overview of the Antibiotic resistant "Priority Pathogens" Published by WHO
- 4.4. Key Industry Developments- Mergers, Acquisitions, Partnerships, etc.
- 4.5. Impact of COVID 19 on Global Antibiotics Market
5. Global Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Drug Class
- 5.1.1. Penicillin
- 5.1.2. Cephalosporin
- 5.1.3. Aminoglycosides
- 5.1.4. Tetracyclines
- 5.1.5. Macrolides
- 5.1.6. Fluoroquinolones
- 5.1.7. Sulfonamides
- 5.1.8. Others
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Skin Infections
- 5.2.2. Respiratory Infections
- 5.2.3. Urinary Tract Infections
- 5.2.4. Septicemia
- 5.2.5. Ear Infection
- 5.2.6. Gastrointestinal Infections
- 5.2.7. Others
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Online Pharmacy
- 5.5. Market Analysis, Insights and Forecast - By Geography
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Drug Class
- 6.1.1. Penicillin
- 6.1.2. Cephalosporin
- 6.1.3. Aminoglycosides
- 6.1.4. Tetracyclines
- 6.1.5. Macrolides
- 6.1.6. Fluoroquinolones
- 6.1.7. Sulfonamides
- 6.1.8. Others
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Skin Infections
- 6.2.2. Respiratory Infections
- 6.2.3. Urinary Tract Infections
- 6.2.4. Septicemia
- 6.2.5. Ear Infection
- 6.2.6. Gastrointestinal Infections
- 6.2.7. Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Online Pharmacy
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Drug Class
- 7.1.1. Penicillin
- 7.1.2. Cephalosporin
- 7.1.3. Aminoglycosides
- 7.1.4. Tetracyclines
- 7.1.5. Macrolides
- 7.1.6. Fluoroquinolones
- 7.1.7. Sulfonamides
- 7.1.8. Others
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Skin Infections
- 7.2.2. Respiratory Infections
- 7.2.3. Urinary Tract Infections
- 7.2.4. Septicemia
- 7.2.5. Ear Infection
- 7.2.6. Gastrointestinal Infections
- 7.2.7. Others
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Online Pharmacy
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Drug Class
- 8.1.1. Penicillin
- 8.1.2. Cephalosporin
- 8.1.3. Aminoglycosides
- 8.1.4. Tetracyclines
- 8.1.5. Macrolides
- 8.1.6. Fluoroquinolones
- 8.1.7. Sulfonamides
- 8.1.8. Others
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Skin Infections
- 8.2.2. Respiratory Infections
- 8.2.3. Urinary Tract Infections
- 8.2.4. Septicemia
- 8.2.5. Ear Infection
- 8.2.6. Gastrointestinal Infections
- 8.2.7. Others
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Hospital Pharmacy
- 8.4.2. Retail Pharmacy
- 8.4.3. Online Pharmacy
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Drug Class
- 9.1.1. Penicillin
- 9.1.2. Cephalosporin
- 9.1.3. Aminoglycosides
- 9.1.4. Tetracyclines
- 9.1.5. Macrolides
- 9.1.6. Fluoroquinolones
- 9.1.7. Sulfonamides
- 9.1.8. Others
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Skin Infections
- 9.2.2. Respiratory Infections
- 9.2.3. Urinary Tract Infections
- 9.2.4. Septicemia
- 9.2.5. Ear Infection
- 9.2.6. Gastrointestinal Infections
- 9.2.7. Others
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Hospital Pharmacy
- 9.4.2. Retail Pharmacy
- 9.4.3. Online Pharmacy
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Antibiotics Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Drug Class
- 10.1.1. Penicillin
- 10.1.2. Cephalosporin
- 10.1.3. Aminoglycosides
- 10.1.4. Tetracyclines
- 10.1.5. Macrolides
- 10.1.6. Fluoroquinolones
- 10.1.7. Sulfonamides
- 10.1.8. Others
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Skin Infections
- 10.2.2. Respiratory Infections
- 10.2.3. Urinary Tract Infections
- 10.2.4. Septicemia
- 10.2.5. Ear Infection
- 10.2.6. Gastrointestinal Infections
- 10.2.7. Others
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Hospital Pharmacy
- 10.4.2. Retail Pharmacy
- 10.4.3. Online Pharmacy
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- 11.2.1. GSK plc
- 11.2.2. Bristol-Myers Squibb Company
- 11.2.3. Sandoz Group AG
- 11.2.4. Merck & Co., Inc.
- 11.2.5. Pfizer Inc.
- 11.2.6. Johnson & Johnson Services, Inc.
- 11.2.7. Bayer AG
- 11.2.8. AbbVie Inc
- 11.2.9. Shionogi & Co., Ltd.
- 11.2.10. Abbott
- 11.2.11. Astellas Pharma Inc.
List of Tables
- Table 1: Global Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 2: Global Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 3: Global Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 4: Global Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 5: Global Antibiotics Market Revenue (USD billion) Forecast, by Region, 2021-2034
- Table 6: North America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 7: North America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 8: North America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 9: North America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 10: North America Antibiotics Market Revenue (USD billion) Forecast, By Country, 2021-2034
- Table 11: Europe Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 12: Europe Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 13: Europe Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 14: Europe Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 15: Europe Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 16: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 17: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 18: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 19: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 20: Asia Pacific Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 22: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 23: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 24: Latin America Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 25: Latin America Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Drug Class, 2021-2034
- Table 27: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Application, 2021-2034
- Table 28: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Route of Administration, 2021-2034
- Table 29: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, by Distribution Channel, 2021-2034
- Table 30: Middle East & Africa Antibiotics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Antibiotics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
- Figure 2: Global Antibiotics Market Value Share (%), by Drug Class, 2025 & 2034
- Figure 3: Global Antibiotics Market Value Share (%), by Application, 2025 & 2034
- Figure 4: Global Antibiotics Market Value Share (%), by Route of Administration, 2025 & 2034
- Figure 5: Global Antibiotics Market Value Share (%), by Distribution Channel, 2025 & 2034
- Figure 6: Global Antibiotics Market Value Share (%), by Region, 2025 & 2034
- Figure 7: North America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
- Figure 8: North America Antibiotics Market Value Share (%), by Drug Class, 2025
- Figure 9: North America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
- Figure 10: North America Antibiotics Market Value Share (%), by Application, 2025
- Figure 11: North America Antibiotics Market Value (USD billion), by Route of Administration, 2025 & 2034
- Figure 12: North America Antibiotics Market Value Share (%), by Route of Administration, 2025
- Figure 13: North America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 14: North America Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 15: North America Antibiotics Market Value (USD billion), By Country, 2025 & 2034
- Figure 16: North America Antibiotics Market Value Share (%), By Country, 2025
- Figure 17: Europe Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
- Figure 18: Europe Antibiotics Market Value Share (%), by Drug Class, 2025
- Figure 19: Europe Antibiotics Market Value (USD billion), by Application, 2025 & 2034
- Figure 20: Europe Antibiotics Market Value Share (%), by Application, 2025
- Figure 21: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 22: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 23: Europe Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 24: Europe Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 25: Europe Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 26: Europe Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 27: Asia Pacific Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
- Figure 28: Asia Pacific Antibiotics Market Value Share (%), by Drug Class, 2025
- Figure 29: Asia Pacific Antibiotics Market Value (USD billion), by Application, 2025 & 2034
- Figure 30: Asia Pacific Antibiotics Market Value Share (%), by Application, 2025
- Figure 31: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 32: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 33: Asia Pacific Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 34: Asia Pacific Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 35: Asia Pacific Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 36: Asia Pacific Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 37: Latin America Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
- Figure 38: Latin America Antibiotics Market Value Share (%), by Drug Class, 2025
- Figure 39: Latin America Antibiotics Market Value (USD billion), by Application, 2025 & 2034
- Figure 40: Latin America Antibiotics Market Value Share (%), by Application, 2025
- Figure 41: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 42: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 43: Latin America Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 44: Latin America Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 45: Latin America Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 46: Latin America Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 47: Middle East & Africa Antibiotics Market Value (USD billion), by Drug Class, 2025 & 2034
- Figure 48: Middle East & Africa Antibiotics Market Value Share (%), by Drug Class, 2025
- Figure 49: Middle East & Africa Antibiotics Market Value (USD billion), by Application, 2025 & 2034
- Figure 50: Middle East & Africa Antibiotics Market Value Share (%), by Application, 2025
- Figure 51: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 52: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 53: Middle East & Africa Antibiotics Market Value (USD billion), by Distribution Channel, 2025 & 2034
- Figure 54: Middle East & Africa Antibiotics Market Value Share (%), by Distribution Channel, 2025
- Figure 55: Middle East & Africa Antibiotics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
- Figure 56: Middle East & Africa Antibiotics Market Value Share (%), By Country/ Sub-region, 2025
- Figure 57: Global Antibiotics Market Share (%), By Company, 2025
